MedPath

SupremeCure Pharma Inc.

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Phase I Study of SC-43 Oral Solution in Subjects With Refractory Solid Tumors

Phase 1
Withdrawn
Conditions
Refractory Solid Tumor
Interventions
Drug: SC-43 Oral Solution
First Posted Date
2018-02-23
Last Posted Date
2020-10-22
Lead Sponsor
SupremeCure Pharma Inc.
Registration Number
NCT03443622

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.